Predictors of poor mental and physical health status among patients with chronic hepatitis C infection: The Chronic Hepatitis Cohort Study (CHeCS)

Hepatology

Volumn 61, Issue 3, 2015, Pages 802-811

  Boscarino, Joseph A ^a   Lu, Mei ^b   Moorman, Anne C ^c   Gordon, Stuart C ^b   Rupp, Loralee B ^b   Spradling, Philip R ^c   Teshale, Eyasu H ^c   Schmidt, Mark A ^d   Vijayadeva, Vinutha ^d   Holmberg, Scott D ^c  

^a GEISINGER HEALTH SYSTEM   (United States)

^b HENRY FORD HEALTH SYSTEM   (United States)

^c CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^d KAISER PERMANENTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ALCOHOL ABUSE; ANTIVIRAL THERAPY; ARTICLE; BLACK PERSON; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; COLLEGE; COMORBIDITY; DEMOGRAPHY; DEPRESSION; EDUCATIONAL STATUS; ELECTRONIC MEDICAL RECORD; EMPLOYMENT STATUS; FEMALE; HEALTH BEHAVIOR; HEALTH CARE SYSTEM; HEALTH STATUS; HEALTH SURVEY; HEPATITIS C; HIGH SCHOOL; HUMAN; INTRAVENOUS DRUG ABUSE; LIFE STRESS; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; MENTAL HEALTH; PREDICTOR VARIABLE; PRIORITY JOURNAL; QUALITY OF LIFE; RISK FACTOR; SEX DIFFERENCE; SMOKING; SOCIAL SUPPORT; SUBSTANCE USE; TREATMENT RESPONSE; AGED; MIDDLE AGED; PSYCHOLOGY;

ADULT; AGED; COHORT STUDIES; DEPRESSION; FEMALE; HEALTH STATUS; HEPATITIS C, CHRONIC; HUMANS; MALE; MENTAL HEALTH; MIDDLE AGED; SOCIAL SUPPORT;

EID: 84923293017     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.27422     Document Type: Article

References (44)

1. Denniston MM, Jiles RB, Drobeniuc J, Klevens RM, Ward JW, McQuillan GM, et al. Chronic hepatitis C virus infection in the United States, National Health and Nutrition Examination Survey 2003 to 2010. Ann Intern Med 2014;160:293-300.
2. Moorman AC, Gordon SC, Rupp LB, Spradling PR, Teshale EH, Lu M, et al. Baseline characteristics and mortality among people in care for chronic viral hepatitis: the Chronic Hepatitis Cohort Study. Clin Infect Dis 2013;56:40-50.
3. Spradling PR, Rupp L, Moorman AC, Lu M, Teshale EH, Gordon SC, et al. Hepatitis B and C virus infection among 1.2 million persons with access to care: factors associated with testing and infection prevalence. Clin Infect Dis 2012;55:1047-1055.
4. Centers for Disease Control and Prevention (CDC). Locations and reasons for initial testing for hepatitis C infection-chronic hepatitis cohort study, United States, 2006-2010. MMWR Morb Mortal Wkly Rep 2013;62:645-648.
5. Smith KJ, Norris S, O'Farrelly C, O'Mara SM. Risk factors for the development of depression in patients with hepatitis C taking interferon-alpha. Neuropsychiatr Dis Treat 2011;7:275-292.
6. Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, et al. Effects of sofosbuvir-based treatment, with and without interferon, on outcome and productivity of patients with chronic hepatitis C. Clin Gastroenterol Hepatol 2014;12:1349-1359.
7. Strauss E, Porto-Ferreira FA, de Almeida-Neto C, Teixeira MC. Altered quality of life in the early stages of chronic hepatitis C is due to the virus itself. Clin Res Hepatol Gastroenterol 2014;38:40-45.
8. Matsushita H, Ikeda F, Iwasaki Y, Seki H, Nanba S, Takeuchi Y, et al. Assessment of health-related quality of life and how it predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C. J Gastroenterol Hepatol 2014;29:337-343.
9. Bezemer G, Van Gool AR, Verheij-Hart E, Hansen BE, Lurie Y, Esteban JI, et al. Long-term effects of treatment and response in patients with chronic hepatitis C on quality of life. An international, multicenter, randomized, controlled study. BMC Gastroenterol 2012;12:11-230X-12-11.
10. Boscarino JA, Adams RE. PTSD onset and course following the World Trade Center disaster: findings and implications for future research. Soc Psychiatry Psychiatr Epidemiol 2009;44:887-898.
11. Boscarino JA, Hoffman SN, Adams RE, Figley CR, Solhkhah R. Mental health outcomes among vulnerable residents after Hurricane Sandy: implications for disaster research and planning. Am J Disaster Med 2014;9:107-120.
12. Adams RE, Boscarino JA. A structural equation model of perievent panic and posttraumatic stress disorder after a community disaster. J Trauma Stress 2011;24:61-69.
13. Adams RE, Boscarino JA, Galea S. Social and psychological resources and health outcomes after the World Trade Center disaster. Soc Sci Med 2006;62:176-188.
14. Yamashita J. A review of psychological assessments for disaster mental health studies. Psychol Trauma 2012;4:560-567.
15. Slobodin O, Caspi Y, Klein E, Berger BD, Hobfoll SE. Resource loss and posttraumatic responses in Bedouin members of the Israeli Defense Forces. J Trauma Stress 2011;24:54-60.
16. Kroenke K, Strine TW, Spitzer RL, Williams JB, Berry JT, Mokdad AH. The PHQ-8 as a measure of current depression in the general population. J Affect Disord 2009;114:163-173.
17. Strine TW, Mokdad AH, Balluz LS, Gonzalez O, Crider R, Berry JT, et al. Depression and anxiety in the United States: findings from the 2006 Behavioral Risk Factor Surveillance System. Psychiatr Serv 2008;59:1383-1390.
18. Turner-Bowker DM, Bayliss MS, Ware JE Jr, Kosinski M. Usefulness of the SF-8 Health Survey for comparing the impact of migraine and other conditions. Qual Life Res 2003;12:1003-1012.
19. Ware JE Jr, Kosinski M, Bjorner JB, Bayliss MS, Batenhorst A, Dahlöf CG, et al. Applications of computerized adaptive testing (CAT) to the assessment of headache impact. Qual Life Res 2003;12:935-952.
20. Stewart AL, Hays RD, Ware JE Jr. The MOS short-form general health survey. Reliability and validity in a patient population. Med Care 1988;26:724-735.
21. Stewart AL, Greenfield S, Hays RD, Wells K, Rogers WH, Berry SD, et al. Functional status and well-being of patients with chronic conditions. Results from the Medical Outcomes Study. JAMA 1989;262:907-913.
22. Stewart AL, Ware JE, eds. Measuring functioning and well-being: the Medical Outcomes Study Approach. Durham, NC: Duke University Press; 1992.
23. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to score version 2 of the SF-12-v2 Health Survey. Boston, MA: Health Assessment Lab; 2002.
24. Ware JE, Kosinski M, Turner-Bowker DM, Gandek B. How to score the SF-8 Health Survey. Boston, MA: Health Assessment Lab; 2001.
25. Bradley KA, Bush KR, McDonell MB, Malone T, Fihn SD. Screening for problem drinking: comparison of CAGE and AUDIT. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. J Gen Intern Med 1998;13:379-388.
26. Bush K, Kivlahan DR, McDonell MB, Fihn SD, Bradley KA. The AUDIT alcohol consumption questions (AUDIT-C): an effective brief screening test for problem drinking. Ambulatory Care Quality Improvement Project (ACQUIP). Alcohol Use Disorders Identification Test. Arch Intern Med 1998;158:1789-1795.
27. Freedy JR, Kilpatrick DG, Resnick HS. Natural disasters and mental health: theory, assessment, and intervention. J Soc Behav Personal 1993;8:49-103.
28. Sherbourne CD, Stewart AL. The MOS social support survey. Soc Sci Med 1991;32:705-714.
29. National Center for Health Statistics. U.S. Census 2000 population with bridged categories. Vol (PHS) 2003-1335. Hyattsville, MD: U.S. Dept. of Health and Human Services, Centers for Disease Control and Prevention, National Center for Health Statistics; 2003.
30. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 1987;40:373-383.
31. Sundararajan V, Henderson T, Perry C, Muggivan A, Quan H, Ghali WA. New ICD-10 version of the Charlson comorbidity index predicted in-hospital mortality. J Clin Epidemiol 2004;57:1288-1294.
32. de Groot V, Beckerman H, Lankhorst GJ, Bouter LM. How to measure comorbidity. A critical review of available methods. J Clin Epidemiol 2003;56:221-229.
33. Austin SR, Wong YN, Uzzo RG, Beck JR, Egleston BL. Why summary comorbidity measures such as the Charlson Comorbidity Index and Elixhauser Score work. Med Care 2013; [Epub ahead of print].
34. Stata Corporation. Stata, Version 13.1. College Station, TX: 2013.
35. Ironson G, Hayward H. Do positive psychosocial factors predict disease progression in HIV-1? A review of the evidence. Psychosom Med 2008;70:546-554.
36. Gore-Felton C, Koopman C. Behavioral mediation of the relationship between psychosocial factors and HIV disease progression. Psychosom Med 2008;70:569-574.
37. Lee K, Otgonsuren M, Younoszai Z, Mir HM, Younossi ZM. Association of chronic liver disease with depression: a population-based study. Psychosomatics 2013;54:52-59.
38. Matsushita H, Ikeda F, Iwasaki Y, Seki H, Nanba S, Takeuchi Y, et al. Assessment of health-related quality of life predicts the outcome of pegylated interferon and ribavirin therapy for chronic hepatitis C. J Gastroenterol Hepatol 2014;29:337-343.
39. Daltro-Oliveira R, Morais-de-Jesus M, Pettersen KM, Parana R, Quarantini LC. Impact of sustained virologic response on quality of life in chronic HVC carriers. Ann Hepatol 2013;12:399-407.
40. Evon DM, Golin CE, Fried MW, Keefe FJ. Chronic hepatitis C and antiviral treatment regimens: where can psychology contribute? J Consult Clin Psychol 2013;81:361-374.
41. Chhatwal J, Ferrante SA, Brass C, El Khoury AC, Burroughs M, Bacon B, et al. Cost-effectiveness of boceprevir in patients previously treated for chronic hepatitis C genotype 1 infection in the United States. Value Health 2013;16:973-986.
42. Younossi ZM, Stepanova M, Henry L, Gane E, Jacobson IM, Lawitz E, et al. Minimal impact of sofosbuvir and ribavirin on health related quality of life in chronic hepatitis C (CH-C). J Hepatol 2014;60:741-747.
43. Cure S, Bianic F, Gavart S, Curtis S, Lee S, Dusheiko G. Cost-effectiveness of telaprevir in combination with pegylated interferon alpha and ribavirin in previously untreated chronic hepatitis C genotype 1 patients. J Med Econ 2014;17:65-76.
44. Younossi ZM, Singer ME, Mir HM, Henry L, Hunt S. Impact of interferon free regimens on clinical and cost outcomes for chronic hepatitis C genotype 1 patients. J Hepatol 2014;60:530-537.